
Evercore ISI reiterated an Outperform rating on Netflix (NFLX) with a $1,375 price target, citing the streaming giant's perfect Piotroski Score, strong international growth, particularly in Mexico, and projected mid-20s percentage EPS growth through 2028, positioning it as the "strongest financial and competitive franchise." This positive outlook is further bolstered by strategic moves into advertising, including a new partnership integrating Netflix's ad inventory with Amazon Ads, which also prompted KeyBanc to reaffirm its Overweight rating, indicating significant long-term growth vectors in live events and advertising, despite minor regulatory headwinds in some international markets.
Multiple research firms, including Evercore ISI, Bernstein, and KeyBanc, have reinforced a bullish outlook on Netflix (NFLX), with Evercore reiterating an Outperform rating and a $1,375 price target. This sentiment is substantiated by exceptional fundamental strength, evidenced by a perfect Piotroski Score of 9, a 14.84% year-over-year revenue growth rate, and a 37.66% year-to-date stock return. Evercore projects sustained mid-20s percentage EPS growth through 2028, driven by strong international performance, such as record penetration and historically low churn in Mexico, and material long-term growth vectors in live events and advertising. A key strategic development is Netflix's new partnership to integrate its ad inventory into Amazon’s demand-side platform, a move viewed favorably by KeyBanc and Citizens JMP as it diversifies Netflix's ad-tech ecosystem. While core US metrics for penetration and satisfaction remain positive, Evercore did note weaker churn intent trends. The company also faces minor regulatory headwinds, as seen with a fine in Turkey over content deemed to violate 'national and moral values', a risk also impacting peers like Disney Plus and HBO Max.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment